Ara
Toplam kayıt 4, listelenen: 1-4
Impact of bioresorbable scaffold use on procedural features compared with new-generation drug-eluting stents
(Kartal Koşuyolu High Specialization Training and Research Hospital, 2020)
Introduction: Although bioresorbable scaffolds (BRS) are considered a new paradigm in stent technology, operators are often discouraged from implanting BRS because of increased strut thickness, reduced radial force, ...
Switching ticagrelor to 600 mg or 300 mg clopidogrel loading bridge in patients with unstable angina
(MDPI AG, 2021)
Ticagrelor is believed to be a more potent and faster antiplatelet agent compared with clopidogrel and may result in lower ischemic outcomes in patients with acute coronary syndrome. However, the best strategy of switching ...
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
(Termedia Publishing House Ltd., 2020)
Introduction: Elevated risk of adverse events in comparison to metallic stents resulted in withdrawal of everolimus-eluting bioresorbable scaffolds (eBVS), known as the most intensively studied BVS. There is a paucity of ...
Long-term outcomes of absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
(NLM (Medline), 2021)
OBJECTIVE: Bioresorbable vascular scaffolds (BVSs) have been a disappointment in the evolution of drug-eluting stents used in percutaneous coronary intervention because an excessive number of thrombotic complications have ...